Literature DB >> 7478929

Force-inhibiting effect of okadaic acid on skinned rat uterus permeabilized with alpha-toxin.

M Watanabe1, M Nakano.   

Abstract

Effects of okadai acid (OA) on contractile force in rat uterine uterine muscles permeabilized with alpha-toxin were examined. (1) Contractile force activated by Ca2+(10(-6.5) M to 10(-4.4) M) was suppressed by relatively low concentrations of OA (30 to 300 nM). The suppressed force was further decreased after washed out of OA. (2)Addition of 10 microM OA enhanced force. Whereas, the increased tension level fell to less than the control level after washed out of OA. (3)Okadaic acid methyl ester (methyl okadaate), an OA derivative without protein phosphatase inhibition, did not affect contraction. These results suggest that the force-inhibiting effect of OA is a result of interference with contractile elements through inhibition of protein phosphatases (PPs) activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478929     DOI: 10.1007/bf00386172

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  9 in total

1.  Inhibitory effect of a toxin okadaic acid, isolated from the black sponge on smooth muscle and platelets.

Authors:  H Karaki; M Mitsui; H Nagase; H Ozaki; S Shibata; D Uemura
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Receptor-coupled, permeabilized smooth muscle. Role of the phosphatidylinositol cascade, G-proteins, and modulation of the contractile response to Ca2+.

Authors:  T Kitazawa; S Kobayashi; K Horiuti; A V Somlyo; A P Somlyo
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

3.  Effects of okadaic acid on cytosolic calcium concentrations and on contractions of the porcine coronary artery.

Authors:  K Hirano; H Kanaide; M Nakamura
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Structure-activity relationship within a series of okadaic acid derivatives.

Authors:  S Nishiwaki; H Fujiki; M Suganuma; H Furuya-Suguri; R Matsushima; Y Iida; M Ojika; K Yamada; D Uemura; T Yasumoto
Journal:  Carcinogenesis       Date:  1990-10       Impact factor: 4.944

5.  Okadaic acid uncouples myosin light chain phosphorylation and tension in smooth muscle.

Authors:  M G Tansey; M Hori; H Karaki; K E Kamm; J T Stull
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

6.  Direct regulation of smooth muscle contractile elements by second messengers.

Authors:  J Nishimura; C van Breemen
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

7.  Relaxing action of okadaic acid, a black sponge toxin on the arterial smooth muscle.

Authors:  N Ashizawa; F Kobayashi; Y Tanaka; K Nakayama
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

8.  Okadaic acid. Protein phosphatase inhibition and muscle contractile effects.

Authors:  A Takai
Journal:  J Muscle Res Cell Motil       Date:  1988-12       Impact factor: 2.698

9.  Effect of 2,3-butanedione monoxime on smooth-muscle contraction of guinea-pig portal vein.

Authors:  M Watanabe
Journal:  Pflugers Arch       Date:  1993-12       Impact factor: 3.657

  9 in total
  3 in total

1.  Force-inhibiting effect of Ser/Thr protein phosphatase 2A inhibitors on bovine ciliary muscle.

Authors:  Minori Ishida; Kosuke Takeya; Motoi Miyazu; Akitoshi Yoshida; Akira Takai
Journal:  J Smooth Muscle Res       Date:  2015

Review 2.  Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology.

Authors:  Akira Takai; Masumi Eto; Katsuya Hirano; Kosuke Takeya; Toshiyuki Wakimoto; Masaru Watanabe
Journal:  J Physiol Sci       Date:  2017-07-05       Impact factor: 2.781

3.  Inhibitory effects of rubratoxin A, a potent inhibitor of protein phosphatase 2, on the Ca2+-dependent contraction of skinned carotid artery from guinea pig.

Authors:  Yasuyuki Naraki; Masaru Watanabe; Kosuke Takeya
Journal:  J Smooth Muscle Res       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.